Two-layer sustained-release microneedles encapsulating exenatide for type 2 diabetes treatment
A meta-analysis conducted in 20211 disclosed a reduction of allcause mortality by 12 percent
Zepbound , containing the active ingredient tirzepatide , is a newer medication that acts on both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
For example, an insulin that modifies its action based on current glucose levels would be a significant advance for everyone who uses insulin, not just those with type 1 diabetes
The Medication Thats Rewriting Weight-Loss Rules Published Date: September 2, 2025 Introduction - From blood sugar control to body weight transformation Until very recently, medical therapy for obesity delivered only modest wins
These 25 Probiotics Actually Help This guide explains how probiotics may support people taking GLP-1 medications, reviews the science, and lists 25 expert-recommended probiotic products
